Diabetes · Philadelphia area, PA
Diabetes studies in Philadelphia area, PA
19 recruiting studies have a site in the Philadelphia area. This page includes nearby cities such as Upland, Bryn Mawr, Wynnewood, Abington.
19 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Philadelphia, PA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Vertex Pharmaceuticals Incorporated
- Location
- Media, PA + 57 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- Philadelphia, PA + 33 other US sites
- Eligibility basics
- Ages 1–25
- RecruitingPhase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
SAb Biotherapeutics, Inc.
- Location
- Philadelphia, PA + 20 other US sites
- Eligibility basics
- Ages 5–40
- RecruitingPhase 1
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
Genentech, Inc.
- Location
- Erie, PA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Eli Lilly and Company
- Location
- Media, PA + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Vertex Pharmaceuticals Incorporated
- Location
- Philadelphia, PA + 9 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Philadelphia, PA + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Zucara Therapeutics Inc.
- Location
- Philadelphia, PA + 36 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
Vertex Pharmaceuticals Incorporated
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteers
Phenotyping Genetic Risk for Type 2 Diabetes
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 10–70
- RecruitingHealthy volunteers
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
Johns Hopkins Bloomberg School of Public Health
- Location
- Philadelphia, PA + 4 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteers
Transformative Research in Diabetic Nephropathy 2.0
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Columbia University
- Location
- Philadelphia, PA + 15 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy
Jaeb Center for Health Research
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 18+ · Women only
- RecruitingHealthy volunteers
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
Thomas Jefferson University
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+ · Women only
- RecruitingHealthy volunteers
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes
Thomas Jefferson University
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+ · Women only
- RecruitingHealthy volunteers
Novel Glaucoma Diagnostics
Wills Eye
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+
Who these studies look for
Studies commonly set an HbA1c range, a diagnosis duration and a list of allowed or excluded medications. Some also recruit people without diabetes as a comparison group.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.